4//SEC Filing
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD 4
Accession 0001400482-17-000061
CIK 0001400482operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 2:16 PM ET
Size
5.8 KB
Accession
0001400482-17-000061
Insider Transaction Report
Form 4
DANSE EDWARD H
Chief Business Officer
Transactions
- Sale
Common Stock
2017-06-01$7.38/sh−1,080$7,970→ 70,134 total
Footnotes (3)
- [F1]On November 30, 2016, the issuer completed its change in place of incorporation, pursuant to which Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation ("Kubota Holdings"), became the publicly traded parent company of the Kubota group of companies. Each issued and outstanding share of common stock of Acucela Inc., a Washington corporation ("Acucela US"), was cancelled and converted into one share of common stock of Kubota Holdings. Pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended, Kubota Holdings is the successor issuer to Acucela US.
- [F2]The issuer's common stock trades on the Tokyo Stock Exchange under the code 4596.
- [F3]The sale on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the vesting of shares under the reporting person's restricted stock grant.
Documents
Issuer
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
CIK 0001400482
Entity typeoperating
Related Parties
1- filerCIK 0001400482
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 2:16 PM ET
- Size
- 5.8 KB